Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Tsang, Chi M ^a   Cheung, Yuk C ^a   Lui, Vivian Wai Yan ^b   Yip, Yim L ^a   Zhang, Guitao ^a,c   Lin, Victor W ^a   Cheung, Kenneth Chat Pan ^a   Feng, Yibin ^d   Tsao, Sai W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MEGADOSE; EPSTEIN BARR VIRUS; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUDE MOUSE; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BERBERINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FIBROBLASTS; HUMANS; INTERLEUKIN-6; MALE; MICE; NASOPHARYNGEAL NEOPLASMS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84891368877     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-619     Document Type: Article

References (41)

1. da Rocha AB, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol 2001, 1(4):364-369. 10.1016/S1471-4892(01)00063-7, 11710734.
2. Albini A, Tosetti F, Li VW, Noonan DM, Li WW. Cancer prevention by targeting angiogenesis. Nat Rev Clin Oncol 2012, 9(9):498-509. 10.1038/nrclinonc.2012.120, 22850752.
3. Katiyar SK, Meeran SM, Katiyar N, Akhtar S. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinogen 2009, 48(1):24-37.
4. Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine 2010, 17(6):436-440. 10.1016/j.phymed.2009.08.012, 19800775.
5. Wang XN, Han X, Xu LN, Yin LH, Xu YW, Qi Y, Peng JY. Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomedicine 2008, 15(12):1062-1068. 10.1016/j.phymed.2008.05.002, 18579357.
6. Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-Cancer Drugs 2009, 20(9):757-769. 10.1097/CAD.0b013e328330d95b, 19704371.
7. Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 2009, 126(1):5-17. 10.1016/j.jep.2009.08.009, 19686830.
8. Zhang L, Yang L, Zheng X. A study of Helicobacterium pylori and prevention and treatment of chronic atrophic gastritis. J Trad Chin-Med 1997, 17(1):3-9.
9. Tsang CM, Lau EP, Di K, Cheung PY, Hau PM, Ching YP, Wong YC, Cheung AL, Wan TS, Tong Y, et al. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med 2009, 24(1):131-138.
10. Liu SJ, Sun YM, Tian DF, He YC, Zeng L, He Y, Ling CQ, Sun SH. Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma. Brit J Cancer 2008, 98(2):363-369. 10.1038/sj.bjc.6604167, 2361469, 18219290.
11. Tang F, Wang D, Duan C, Huang D, Wu Y, Chen Y, Wang W, Xie C, Meng J, Wang L, et al. Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8 F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567. J Biol Chem 2009, 284(40):27456-27466. 10.1074/jbc.M109.033795, 2785675, 19651779.
12. Wang N, Feng Y, Zhu M, Tsang CM, Man K, Tong Y, Tsao SW. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 2010, 111(6):1426-1436. 10.1002/jcb.22869, 20830746.
13. Liu J, He C, Zhou K, Wang J, Kang JX. Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells. Biochem Biophys Res Commun 2009, 378(2):174-178. 10.1016/j.bbrc.2008.10.169, 3454467, 19000652.
14. Peng PL, Kuo WH, Tseng HC, Chou FP. Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int J Radiat Oncol Biol Phys 2008, 70(2):529-542. 10.1016/j.ijrobp.2007.08.034, 18207031.
15. Chan AT, Teo PM, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol 2002, 13(7):1007-1015. 10.1093/annonc/mdf179, 12176778.
16. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell 2004, 5(5):423-428. 10.1016/S1535-6108(04)00119-9, 15144950.
17. Tsang CM, Zhang G, Seto E, Takada K, Deng W, Yip YL, Man C, Hau PM, Chen H, Cao Y, et al. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. Int J Cancer 2010, 127(7):1570-1583. 10.1002/ijc.25173, 20091869.
18. Tsao SW, Tsang CM, Pang PS, Zhang G, Chen H, Lo KW. The biology of EBV infection in human epithelial cells. Semin Cancer Biol 2012, 22(2):137-143. 10.1016/j.semcancer.2012.02.004, 22497025.
19. Ho Y, Tsao SW, Zeng M, Lui VW. STAT3 as a therapeutic target for Epstein-Barr virus (EBV) - associated nasopharyngeal carcinoma. Cancer Lett 2013, 330(2):141-149. 10.1016/j.canlet.2012.11.052, 23220625.
20. Bromberg J, Darnell JE. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000, 19(21):2468-2473. 10.1038/sj.onc.1203476, 10851045.
21. Yu H, Jove R. The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 2004, 4(2):97-105. 10.1038/nrc1275, 14964307.
22. Lui VW, Wong EY, Ho Y, Hong B, Wong SC, Tao Q, Choi GC, Au TC, Ho K, Yau DM, et al. STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. Int J Cancer 2009, 125(8):1884-1893. 10.1002/ijc.24567, 19588483.
23. Liu YP, Tan YN, Wang ZL, Zeng L, Lu ZX, Li LL, Luo W, Tang M, Cao Y. Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma. Int J Mol Med 2008, 21(2):153-162.
24. Chow KC, Chiou SH, Ho SP, Tsai MH, Chen CL, Wang LS, Chi KH. The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma. Oncol Reports 2003, 10(4):813-819.
25. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, Lee JC. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 1999, 83(1):121-126. 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F, 10449618.
26. Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS, Li YP. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA 1989, 86(23):9524-9528. 10.1073/pnas.86.23.9524, 298529, 2556716.
27. Huang DP, Ho JH, Poon YF, Chew EC, Saw D, Lui M, Li CL, Mak LS, Lai SH, Lau WH. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer 1980, 26(2):127-132. 10.1002/ijc.2910260202, 6259064.
28. Li HM, Man C, Jin Y, Deng W, Yip YL, Feng HC, Cheung YC, Lo KW, Meltzer PS, Wu ZG, et al. Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase. Int J Cancer 2006, 119(7):1567-1576. 10.1002/ijc.22032, 16688717.
29. Romijn JC, Verkoelen CF, Schroeder FH. Measurement of the survival of human tumor cells after implantation in athymic nude mice. Int J Cancer 1986, 38(1):97-101. 10.1002/ijc.2910380116, 3721626.
30. Chen H, Hutt-Fletcher L, Cao L, Hayward SD. A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J Virol 2003, 77(7):4139-4148. 10.1128/JVI.77.7.4139-4148.2003, 150666, 12634372.
31. Vicent S, Sayles LC, Vaka D, Khatri P, Gevaert O, Chen R, Zheng Y, Gillespie AK, Clarke N, Xu Y, et al. Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo. Cancer Res 2012, 72(22):5744-5756. 10.1158/0008-5472.CAN-12-1097, 3856949, 22962265.
32. Lui VW, Yau DM, Wong EY, Ng YK, Lau CP, Ho Y, Chan JP, Hong B, Ho K, Cheung CS, et al. Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells. Carcinogenesis 2009, 30(12):2085-2094. 10.1093/carcin/bgp253, 19843642.
33. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009, 9(11):798-809. 10.1038/nrc2734, 19851315.
34. Wang X, Crowe PJ, Goldstein D, Yang JL. STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (Review). Int J Oncol 2012, 41(4):1181-1191.
35. Dave B, Landis MD, Dobrolecki LE, Wu MF, Zhang X, Westbrook TF, Hilsenbeck SG, Liu D, Lewis MT, Tweardy DJ, et al. Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model. PloS one 2012, 7(8):e30207. 10.1371/journal.pone.0030207, 3412855, 22879872.
36. Kataoka K, Kim DJ, Carbajal S, Clifford JL, DiGiovanni J. Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis. Carcinogenesis 2008, 29(6):1108-1114. 10.1093/carcin/bgn061, 2902397, 18453544.
37. Ling X, Arlinghaus RB. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. Cancer Res 2005, 65(7):2532-2536. 10.1158/0008-5472.CAN-04-2425, 15805244.
38. Kowalewski Z, Mrozikiewicz A, Bobkiewicz T, Drost K, Hladon B. Toxicity of berberine sulfate. Acta poloniae pharmaceutica 1975, 32(1):113-120.
39. Zhang GT, Deng W, Yip YL, Lui VW, Wong SC, Cheung AL, Hau PM, Zeng M, Lung ML, Chen H, Lo KW, Takada K, Tsao SW, CM Enhanced IL-6/IL-6R signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells. PloS one 2013, in press, CM.
40. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann N Y Acad Sci 2009, 1171:59-76. 10.1111/j.1749-6632.2009.04911.x, 3141289, 19723038.
41. Neurath MF, Finotto S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev 2011, 22(2):83-89. 10.1016/j.cytogfr.2011.02.003, 21377916.